Filter News
Area of Research
News Topics
- (-) Biomedical (1)
- (-) Clean Water (2)
- (-) Cybersecurity (1)
- (-) Materials Science (2)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (7)
- Artificial Intelligence (1)
- Bioenergy (5)
- Composites (1)
- Computer Science (1)
- Environment (4)
- Grid (1)
- Machine Learning (1)
- Mercury (1)
- Neutron Science (6)
- Security (1)
- Sustainable Energy (5)
- Transportation (4)
Media Contacts
While Tsouris’ water research is diverse in scope, its fundamentals are based on basic science principles that remain largely unchanged, particularly in a mature field like chemical engineering.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
The National Alliance for Water Innovation, a partnership of the Department of Energy’s Oak Ridge National Laboratory, other national labs, university and private sector partners, has been awarded a five-year, $100 million Energy-Water Desalination Hub by DOE to address water security issues in the United States.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.